Pinnacle Financial Group, Inc.’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
Pinnacle Financial Group, Inc.'s LUCD Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Lucid Diagnostics (LUCD) in Q3 2026: 60 shares worth $45. The stake represents ﹤0.01% of the portfolio and ranks #2240 among its holdings.
115 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.
- Pinnacle Financial Group, Inc. held 60 shares of Lucid Diagnostics worth $45 as of Q3 2026.
- Lucid Diagnostics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Lucid Diagnostics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #2240 holding.
- 115 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.